These results demonstrated that suppressed ENO1 inhibited cell glycolysis, proliferation, migration, and invasion by inactivating FAK-mediated PI3K/AKT pathway in NSCLC. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.